HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Cosmetics Director: ‘Sporadic’ WEN AERs Make Case For Mandatory Reporting

This article was originally published in The Rose Sheet

Executive Summary

In a Q&A posting, FDA Office of Cosmetics and Colors Director Linda Katz offered perspective on how the division handles adverse event reports and makes a case for mandatory AE reporting. She also explains how FDA reacted when WEN-related AERs began rolling in.


Related Content

Cosmetics Recalls For August-October Period Have One Familiar Thing In Common: All Were Voluntary
FDA To Curtail Cosmetics Safety Work Under FY 2018 Budget Constraints
FDA Research Seeks Better Understanding Of Talc’s Potential Cancer Link
2016 In Review: FDA Transparency, Claims Enforcement A One-Off?
Cosmetics Adverse Events Under Spotlight In FDA Transparency Push
Consumers, Health Practitioners Heeded FDA’s Call For WEN-Related AEs
WEN Attorneys Meet With Top FDA Officials In ‘Continued Cooperation’
J&J Talc Verdict Spells Opportunity For Plaintiffs, Talc-Free Powder Market
FDA: No Asbestos Found In Talc Products Sampled, But Results Limited
Petition against cosmetic talc


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts